BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Sarcomas AND KIT, C-Kit, 3815, ENSG00000157404, CD117, SCFR, P10721 AND Treatment
650 results:

  • 1. Polyphyllin I enhances tumor necrosis factor-related apoptosis-inducing ligand-induced inhibition of human osteosarcoma cell growth downregulating the Wnt/β-catenin pathway.
    Junli C; Fulai Z; Xingyuan S; Xiaoping MA; Peng Z; Chujie Z; Binhao S; Wenchao GU; Yongjun W; Yanping Y
    J Tradit Chin Med; 2024 Apr; 44(2):251-259. PubMed ID: 38504531
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Effect of Staphylococcal Nuclease and Tudor Domain Containing 1/SLC7A11 on the Occurrence and Development of Osteosarcoma by Inhibiting Ferroptosis].
    Wang ST; Xu SJ; Gui P; Li XN; Sui YH; Li ZX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2024 Feb; 46(1):11-18. PubMed ID: 38433625
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Screening for Synergistic Reagents With Pazopanib Against Osteosarcoma Using a Compound Library.
    Yada Y; Asanuma K; Kakimto T; Okuno K; Okamoto T; Iino T; Nakamura T; Sudo A
    Anticancer Res; 2024 Mar; 44(3):1071-1078. PubMed ID: 38423639
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. kit mutations and expression: current knowledge and new insights for overcoming IM resistance in GIST.
    Zhou S; Abdihamid O; Tan F; Zhou H; Liu H; Li Z; Xiao S; Li B
    Cell Commun Signal; 2024 Feb; 22(1):153. PubMed ID: 38414063
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. kit ATP-Binding Pocket/Activation Loop Mutations in GI Stromal Tumor: Emerging Mechanisms of Kinase Inhibitor Escape.
    Mühlenberg T; Falkenhorst J; Schulz T; Fletcher BS; Teuber A; Krzeciesa D; Klooster I; Lundberg M; Wilson L; Lategahn J; von Mehren M; Grunewald S; Tüns AI; Wardelmann E; Sicklick JK; Brahmi M; Serrano C; Schildhaus HU; Sievers S; Treckmann J; Heinrich MC; Raut CP; Ou WB; Marino-Enriquez A; George S; Rauh D; Fletcher JA; Bauer S
    J Clin Oncol; 2024 Apr; 42(12):1439-1449. PubMed ID: 38408285
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Effective treatment of Anlotinib Combined With Chemotherapy in Children With Desmoplastic Small Round Cell Tumor: A Case Series in a Single-center and Literature Review.
    Jing XY; Shen CQ; He GQ; Xu RR; Gao J; Guo X
    J Pediatr Hematol Oncol; 2024 Apr; 46(3):159-164. PubMed ID: 38408140
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Longitudinal plasma proteomic analysis identifies biomarkers and combinational targets for anti-PD1-resistant cancer patients.
    Tan Q; Gao R; Zhang X; Yang J; Xing P; Yang S; Wang D; Wang G; Wang S; Yao J; Zhang Z; Tang L; Yu X; Han X; Shi Y
    Cancer Immunol Immunother; 2024 Feb; 73(3):47. PubMed ID: 38349411
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. kit/PDGFRA inhibitors for the treatment of gastrointestinal stromal tumors: getting to the gist of the problem.
    Cicala CM; Olivares-Rivas I; Aguirre-Carrillo JA; Serrano C
    Expert Opin Investig Drugs; 2024 Mar; 33(3):159-170. PubMed ID: 38344849
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Angiosarcoma of gallbladder, a literature review.
    Salehi M; Rehman S; Davis S; Jafari HR
    J Med Case Rep; 2024 Jan; 18(1):62. PubMed ID: 38291481
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Circ_0000376 regulates miR-577/HK2/LDHA signaling pathway to promote the growth, invasion and glycolysis of osteosarcoma.
    Dai H; Yi G; Jiang D; Min Y; Li Z
    J Orthop Surg Res; 2024 Jan; 19(1):67. PubMed ID: 38218855
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Ripretinib versus sunitinib in gastrointestinal stromal tumor: ctDNA biomarker analysis of the phase 3 INTRIGUE trial.
    Heinrich MC; Jones RL; George S; Gelderblom H; Schöffski P; von Mehren M; Zalcberg JR; Kang YK; Razak AA; Trent J; Attia S; Le Cesne A; Siontis BL; Goldstein D; Boye K; Sanchez C; Steeghs N; Rutkowski P; Druta M; Serrano C; Somaiah N; Chi P; Reichmann W; Sprott K; Achour H; Sherman ML; Ruiz-Soto R; Blay JY; Bauer S
    Nat Med; 2024 Feb; 30(2):498-506. PubMed ID: 38182785
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Activation of HDAC8 Can Suppress the Proliferation of Osteosarcoma Cells via
    Wang L; Bai X; Zhang X; Wang X; Chen S; Wu S; Lin L
    Ann Clin Lab Sci; 2023 Nov; 53(6):920-930. PubMed ID: 38182151
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Avapritinib-based SAR studies unveil a binding pocket in kit and PDGFRA.
    Teuber A; Schulz T; Fletcher BS; Gontla R; Mühlenberg T; Zischinsky ML; Niggenaber J; Weisner J; Kleinbölting SB; Lategahn J; Sievers S; Müller MP; Bauer S; Rauh D
    Nat Commun; 2024 Jan; 15(1):63. PubMed ID: 38167404
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Troponin T1 silencing inhibits paclitaxel resistance and the development of breast cancer via suppressing rat sarcoma virus/rapidly accelerated fibrosarcoma 1 pathway.
    Zhu T; Zhou P; Yang L; Fang X; Zhi X
    Environ Toxicol; 2024 Apr; 39(4):2064-2076. PubMed ID: 38095131
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Cirsiliol induces autophagy and mitochondrial apoptosis through the AKT/FOXO1 axis and influences methotrexate resistance in osteosarcoma.
    Luo M; Su Z; Gao H; Tan J; Liao R; Yang J; Lin L
    J Transl Med; 2023 Dec; 21(1):907. PubMed ID: 38087310
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Advanced systemic mastocytosis-Revised classification, new drugs and how we treat.
    Pardanani A; Reichard K; Tefferi A
    Br J Haematol; 2024 Feb; 204(2):402-414. PubMed ID: 38054381
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. treatment of acral and mucosal melanoma: Current and emerging targeted therapies.
    Zhang J; Tian H; Mao L; Si L
    Crit Rev Oncol Hematol; 2024 Jan; 193():104221. PubMed ID: 38036156
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Small gastric synovial sarcoma diagnosed and treatment by laparoscopic-endoscopic cooperative surgery: a case report.
    Sato Y; Morita S; Yoshida A; Yoshinaga S; Nishida T
    Clin J Gastroenterol; 2024 Feb; 17(1):18-22. PubMed ID: 37966703
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. 3-AP inhibits the growth of human osteosarcoma by decreasing the activity of the iron-dependent pathway.
    Huang S; Zhang D; Yi X; Liu C; Jian C; Yu A
    Med Oncol; 2023 Nov; 40(12):353. PubMed ID: 37952032
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. miR-3195 suppresses the malignant progression of osteosarcoma cells via targeting SOX4.
    Liang J; Bao D; Ye Z; Cao B; Jin G; Lu Z; Chen J
    J Orthop Surg Res; 2023 Oct; 18(1):809. PubMed ID: 37904207
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 33.